Bioatla, Inc.

This study tested a new drug called BA3011, both alone and combined with an existing immunotherapy drug, for people with advanced lung cancer that had stopped responding to previous treatments. Researchers wanted to see if this approach was safe and could shrink tumors in 85 adul…

This study tested the safety and effectiveness of a new drug called mecbotamab vedotin (BA3011) for people with advanced solid tumors, including specific types of sarcoma. It involved 245 patients aged 12 and older. The research looked at the drug given alone and in combination w…

This study tested an experimental drug called ozuriftamab vedotin (BA3021) in people with advanced head and neck cancer that had returned or spread. The main goals were to see if the drug could shrink tumors and how safe it was. It included 42 adults whose cancer was not curable …